These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1734947)

  • 61. A functional and phenotypic comparison of murine natural killer (NK) cells and lymphokine-activated killer (LAK) cells.
    Hoskin DW; Stankova J; Anderson SK; Roder JC
    Int J Cancer; 1989 May; 43(5):940-8. PubMed ID: 2469657
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of alpha-IFN on cytokine-induced antigen expression and secretion of TNF, LT and IgM in HCL.
    Hassan IB; Lantz M; Sundström C
    Leuk Res; 1991; 15(10):903-10. PubMed ID: 1921451
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TNF-alpha and IFN-gamma reverse IL-4 inhibition of lymphokine-activated killer cell function.
    Swisher SG; Economou JS; Holmes EC; Golub SH
    Cell Immunol; 1990 Jul; 128(2):450-61. PubMed ID: 2113430
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
    Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
    Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of TNF-alpha and IFN-alpha on the proliferation and cytotoxicity of lymphokine-activated killer cells in patients with bladder cancer.
    Wang Z; Cheng Y; Zheng R; Qin D; Liu G
    Chin Med J (Engl); 1997 Mar; 110(3):180-3. PubMed ID: 9594335
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Interferon-gamma-treated K562 target cells distinguish functional NK cells from lymphokine-activated killer (LAK) cells.
    Powell J; Stone J; Chan WC; Yang ZD; Leatherbury A; Sell KW; Wiktor-Jedrzejczak W; Ahmed-Ansari A
    Cell Immunol; 1989 Feb; 118(2):250-64. PubMed ID: 2491960
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
    Di Raimondo F; LaPushin R; Hersh EM
    Acta Haematol; 1987; 78 Suppl 1():77-83. PubMed ID: 3124452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interferon-alpha activates cytotoxic function but inhibits interleukin-2-mediated proliferation and tumor necrosis factor-alpha secretion by immature human natural killer cells.
    Jewett A; Bonavida B
    J Clin Immunol; 1995 Jan; 15(1):35-44. PubMed ID: 7759599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Endogenous lymphokine activated killer cell activity and cytogenetic response in chronic myelogenous leukaemia treated with alpha-interferon.
    Meseri A; Delwail V; Brizard A; Lecron JC; Pelletier D; Guilhot F; Tanzer J; Goube de Laforest P
    Br J Haematol; 1993 Feb; 83(2):218-22. PubMed ID: 8457470
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A possible role for interferon-alpha and activated natural killer cells in remission of AIDS-related Kaposi's sarcoma: in vitro studies.
    Reiter Z; Ozés ON; Blatt LM; Sturzl M; Taylor MW
    J Acquir Immune Defic Syndr (1988); 1992; 5(5):469-76. PubMed ID: 1560343
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Culture of normal and leukemic bone marrow in interleukin-2: analysis of cell activation, cell proliferation, and cytokine production.
    Klingemann HG; Neerunjun J; Schwulera U; Ziltener HJ
    Leukemia; 1993 Sep; 7(9):1389-93. PubMed ID: 8371589
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [The role of interferons in neuroblastoma. 2: Immunomodulatory effects].
    Handgretinger R; Bruchelt G; Daurer B; Lang P; Dopfer R; Reisfeld RA; Treuner J; Niethammer D
    Klin Padiatr; 1990; 202(4):206-11. PubMed ID: 2118581
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mechanism of interferon action in hairy cell leukemia: a model of effective cancer biotherapy.
    Vedantham S; Gamliel H; Golomb HM
    Cancer Res; 1992 Mar; 52(5):1056-66. PubMed ID: 1737364
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human small-cell lung-cancer cells are cytokine-resistant but NK/LAK-sensitive.
    Lagadec PF; Saraya KA; Balkwill FR
    Int J Cancer; 1991 May; 48(2):311-7. PubMed ID: 1850388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Lymphokine-activated killer (LAK) cells: interferon-gamma synergizes with interleukin-2 to induce LAK cytotoxicity in homogeneous leukemic preparations.
    Kaufmann Y; Davidsohn J; Levanon M; Icekson I; Revel M; Ramot B
    Clin Immunol Immunopathol; 1991 Feb; 58(2):278-88. PubMed ID: 1898716
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Suppression of lymphokine-activated killer (LAK) cell induction mediated by interleukin-4 and transforming growth factor-beta 1: effect of addition of exogenous tumour necrosis factor-alpha and interferon-gamma, and measurement of their endogenous production.
    Brooks B; Chapman K; Lawry J; Meager A; Rees RC
    Clin Exp Immunol; 1990 Dec; 82(3):583-9. PubMed ID: 2124961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
    Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D
    Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.